McAdam »

Cognition Therapeutics shares owned by McAdam

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by McAdam from 13F filings

Historical chart of McAdam investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by McAdam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by McAdam

Quarter filed Position value Share count Share price at filing
2026-03-31 $53k 70k 0.76
2025-12-31 $100k 74k 1.35
2025-09-30 $97k 72k 1.35

More positions owned by McAdam

Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Spdr Series Trust State Street Spd (SPTL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Fidelity Covington Trust Emerg Mkts Mltft (FDEM)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for McAdam

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Vanguard Capital Management
Davenport & Co
Chescapmanager
Renaissance Technologies
BlackRock
Geode Capital Management
Hilton Capital Management
Dauntless Investment Group
Vanguard Fiduciary Trust
CM Management
Jane Street
Sigma Planning
State Street Corporation

View all funds holding Cognition Therapeutics